Envestnet Asset Management
AMPH icon

Envestnet Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Envestnet Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
11,999
-6,269
-34% -$126K ﹤0.01% 4559
2026
Q1 		$358K Sell
18,268
-10,555
-37% -$258K ﹤0.01% 4169
2025
Q4 		$772K Buy
28,823
+6,848
+31% +$176K ﹤0.01% 3422
2025
Q3 		$586K Buy
+21,975
New +$567K ﹤0.01% 3643
2025
Q2 		– Sell
-9,938
Closed -$288K – 4428
2025
Q1 		$288K Sell
9,938
-22,265
-69% -$711K ﹤0.01% 3943
2024
Q4 		$1.2M Sell
32,203
-2,463
-7% -$113K ﹤0.01% 3046
2024
Q3 		$1.68M Buy
34,666
+9,306
+37% +$408K ﹤0.01% 2777
2024
Q2 		$1.01M Buy
25,360
+1,563
+7% +$64.8K ﹤0.01% 3038
2024
Q1 		$1.04M Buy
23,797
+726
+3% +$37.5K ﹤0.01% 2996
2023
Q4 		$1.43M Buy
23,071
+6,146
+36% +$323K ﹤0.01% 2673
2023
Q3 		$778K Buy
16,925
+7,468
+79% +$407K ﹤0.01% 2989
2023
Q2 		$543K Buy
9,457
+380
+4% +$16.8K ﹤0.01% 3155
2023
Q1 		$340K Buy
+9,077
New +$298K ﹤0.01% 3380
2022
Q3 		– Sell
-6,053
Closed -$211K – 3899
2022
Q2 		$211K Sell
6,053
-568
-9% -$20.3K ﹤0.01% 3562
2022
Q1 		$238K Buy
+6,621
New +$188K ﹤0.01% 3578
2017
Q3 		– Sell
-252
Closed -$5K – 2906
2017
Q2 		$5K Sell
252
-18
-7% -$285 ﹤0.01% 2817
2017
Q1 		$4K Buy
270
+77
+40% +$1.21K ﹤0.01% 2918
2016
Q4 		$4K Buy
+193
New +$3.75K ﹤0.01% 2898
2016
Q3 		– Sell
-9,622
Closed -$155K – 2902
2016
Q2 		$155K Hold
9,622
– – ﹤0.01% 2221
2016
Q1 		$115K Buy
+9,622
New +$113K ﹤0.01% 2336

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Envestnet Asset Management's AMPH Position: Q2 2026 in Review

Envestnet Asset Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 34% in Q2 2026, selling an estimated $126K and leaving 11,999 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #4559.

Envestnet Asset Management first reported a position in AMPH in Q1 2016 and has held it in 20 quarters since. The position peaked at $1.68M in Q3 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Envestnet Asset Management held 11,999 shares of Amphastar Pharmaceuticals worth $242K as of Q2 2026.
  • Envestnet Asset Management sold 6,269 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $126K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4559 holding.
  • Envestnet Asset Management first reported a position in Amphastar Pharmaceuticals in Q1 2016 and has held it in 20 quarters since.
  • Envestnet Asset Management's Amphastar Pharmaceuticals position peaked at $1.68M in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.